Novel device to change LV shape for heart failure treatment: device design and implantation procedure

M. Takagaki; K. Fukamachi; P. M. McCarthy; Y. Ochiai; R. Dessoffy; R. Vidlund; T. Paulson; T. Mortier; C. J. Schweich

doi:10.1097/00002480-200003000-00112

Novel device to change LV shape for heart failure treatment: device design and implantation procedure

M. Takagaki^*, K. Fukamachi, P. M. McCarthy, Y. Ochiai, R. Dessoffy, R. Vidlund, T. Paulson, T. Mortier, C. J. Schweich

^*Corresponding author for this work

Surgery, Cardiac Surgery Division

Research output: Contribution to journal › Conference article › peer-review

Abstract

A novel device, the Myocor Myosplint, was designed to produce a decrease in wall stress by changing LV shape to improve contractile function in dilated cardiomyopathy patients. To test the feasibility of the Myosplint implantation, dilated cardiomyopathy was induced in 38 healthy dogs implanted with pacemakers. Once placed, the Myosplints were used to draw the LV walls inward to a prescribed distance. In all cases, three Myosplints were successfully implanted without using cardiopulmonary bypass. There were no complications related to the device or procedure.

Original language	English (US)
Pages (from-to)	178
Number of pages	1
Journal	Unknown Journal
Volume	46
Issue number	2
DOIs	https://doi.org/10.1097/00002480-200003000-00112
State	Published - 2000
Event	46th Annual Conference and Exposition of ASAIO - New York, NY, USA Duration: Jun 28 2000 → Jul 1 2000

ASJC Scopus subject areas

Biophysics
Bioengineering
Biomaterials
Biomedical Engineering

Access to Document

10.1097/00002480-200003000-00112

Cite this

@article{96bf23fa027b4058947ce6c2b5f5fbdd,

title = "Novel device to change LV shape for heart failure treatment: device design and implantation procedure",

abstract = "A novel device, the Myocor Myosplint, was designed to produce a decrease in wall stress by changing LV shape to improve contractile function in dilated cardiomyopathy patients. To test the feasibility of the Myosplint implantation, dilated cardiomyopathy was induced in 38 healthy dogs implanted with pacemakers. Once placed, the Myosplints were used to draw the LV walls inward to a prescribed distance. In all cases, three Myosplints were successfully implanted without using cardiopulmonary bypass. There were no complications related to the device or procedure.",

author = "M. Takagaki and K. Fukamachi and McCarthy, {P. M.} and Y. Ochiai and R. Dessoffy and R. Vidlund and T. Paulson and T. Mortier and Schweich, {C. J.}",

year = "2000",

doi = "10.1097/00002480-200003000-00112",

language = "English (US)",

volume = "46",

pages = "178",

journal = "Free Radical Biology and Medicine",

issn = "0891-5849",

publisher = "Elsevier Inc.",

number = "2",

note = "46th Annual Conference and Exposition of ASAIO ; Conference date: 28-06-2000 Through 01-07-2000",

}

TY - JOUR

T1 - Novel device to change LV shape for heart failure treatment

T2 - 46th Annual Conference and Exposition of ASAIO

AU - Takagaki, M.

AU - Fukamachi, K.

AU - McCarthy, P. M.

AU - Ochiai, Y.

AU - Dessoffy, R.

AU - Vidlund, R.

AU - Paulson, T.

AU - Mortier, T.

AU - Schweich, C. J.

PY - 2000

Y1 - 2000

N2 - A novel device, the Myocor Myosplint, was designed to produce a decrease in wall stress by changing LV shape to improve contractile function in dilated cardiomyopathy patients. To test the feasibility of the Myosplint implantation, dilated cardiomyopathy was induced in 38 healthy dogs implanted with pacemakers. Once placed, the Myosplints were used to draw the LV walls inward to a prescribed distance. In all cases, three Myosplints were successfully implanted without using cardiopulmonary bypass. There were no complications related to the device or procedure.

AB - A novel device, the Myocor Myosplint, was designed to produce a decrease in wall stress by changing LV shape to improve contractile function in dilated cardiomyopathy patients. To test the feasibility of the Myosplint implantation, dilated cardiomyopathy was induced in 38 healthy dogs implanted with pacemakers. Once placed, the Myosplints were used to draw the LV walls inward to a prescribed distance. In all cases, three Myosplints were successfully implanted without using cardiopulmonary bypass. There were no complications related to the device or procedure.

UR - http://www.scopus.com/inward/record.url?scp=0034159485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034159485&partnerID=8YFLogxK

U2 - 10.1097/00002480-200003000-00112

DO - 10.1097/00002480-200003000-00112

M3 - Conference article

AN - SCOPUS:0034159485

VL - 46

SP - 178

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 2

Y2 - 28 June 2000 through 1 July 2000

ER -

Novel device to change LV shape for heart failure treatment: device design and implantation procedure

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this